Thermi

What Thermi does

Thermi (legal entity ThermiGen, LLC) is a privately held Austin, Texas-based medical device company that develops and manufactures temperature-controlled radio frequency (RF) platforms for aesthetic and dermatological procedures. Founded in 2012 in Dallas and relocated to Austin in 2019 following its acquisition by Celling Biosciences, the company operates with 11-50 employees and serves aesthetic clinics, dermatologists, plastic surgeons, and women's health practitioners across the United States. Its technology is built around a 460 kHz RF frequency chosen for optimal tissue penetration and low tissue resistance, governed by proprietary temperature-controlled algorithms.

The company's commercial offering follows a platform-plus-modules architecture. The flagship ThermiRF+ system (20W and 50W outputs) serves as the universal base unit, with interchangeable hand-pieces enabling five distinct treatment modalities: ThermiVa (vaginal rejuvenation), ThermiSmooth (skin smoothing for face and body), ThermiTight (minimally invasive tissue tightening), ThermiEye (periorbital area, launched 2023), and ThermiFit / ThermiFit Mini (body sculpting, launched 2024). All systems carry FDA clearance for dermatological and general surgical electrocoagulation and hemostasis, and European indication for vulvovaginal laxity treatment. The Celling Biosciences partnership creates a parallel RF + Bio initiative integrating regenerative biologics with the RF platform.

Thermi monetizes through a two-layer model: one-time device sales of the ThermiRF+ platform to healthcare providers, and downstream per-treatment usage revenue accruing to providers (illustrated at $400 per ThermiSmooth Face treatment and $700 per Body treatment). Distribution is direct-to-provider via sales representatives, a provider portal (My Thermi), and clinical support infrastructure including an ROI earnings calculator, live trainings, and marketing collateral. The company maintains a Find A Doctor tool on its website that drives patient referrals into provider practices, reinforcing the sales-led go-to-market motion. Total disclosed external funding prior to the 2019 acquisition was $11M, led by Cypress Growth Capital and Silicon Valley Bank in 2015.

Name

Thermi

Legal name

ThermiGen, LLC

Website

https://thermi.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Thermi (ThermiGen, LLC) is a privately held Austin, Texas medical device company that develops FDA-cleared, temperature-controlled 460 kHz radio frequency platforms used by aesthetic clinics, dermatologists, plastic surgeons, and women's health practitioners for non-invasive and minimally invasive cosmetic procedures including skin smoothing, tissue tightening, and vaginal rejuvenation.

Ownership category

akta.pro rank

Product category

Aesthetic Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Laser & Energy-Based Dermatology (HLAKACAF)

Keywords

• Radio frequency devices
• Aesthetic medical equipment
• Dermatology RF systems
• Non-invasive skin treatments
• Temperature-controlled RF platform

Headquarters

HQ city

Austin

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Marketing or Sales, Personnel, Others

Revenue model

1. RF Platform Device Sales: Sale of the ThermiRF and ThermiRF+ multi-modality platform systems to healthcare providers. The platform serves as the hardware base for multiple treatment modalities through interchangeable hand-pieces.
2. Per-Treatment Revenue: Providers generate revenue from each treatment performed using Thermi devices. Treatment pricing varies by procedure type (ThermiSmooth Face at $400/treatment, Body at $700/treatment) and generates recurring per-procedure revenue for practices.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Thermi develops and manufactures temperature-controlled radio frequency (RF) medical devices, anchored by its flagship ThermiRF+ multi-modality platform operating at 460 kHz. The platform supports interchangeable hand-pieces for distinct aesthetic procedures including ThermiVa (vaginal rejuvenation), ThermiSmooth (skin smoothing), ThermiTight (tissue tightening), ThermiEye (eye area treatment), and ThermiFit/ThermiFit Mini (body sculpting). Thermi sells the platform directly to aesthetic clinics, dermatologists, plastic surgeons, and women's health practitioners, FDA-cleared for dermatological and general surgical electrocoagulation and hemostasis.

Product overview

Thermi offers a platform-plus-modules architecture built around the ThermiRF+ temperature-controlled radio frequency platform. The core ThermiRF+ system serves as the foundational technology supporting multiple treatment modalities including ThermiVa (vaginal rejuvenation), ThermiSmooth (skin smoothing), ThermiTight (tissue tightening), ThermiEye (eye area treatment), and ThermiFit/ThermiFit Mini (body sculpting). All devices utilize 460 kHz radio frequency technology with proprietary temperature-controlled algorithms to safely heat targeted tissues, stimulate collagen, and deliver non-invasive to minimally-invasive aesthetic treatments with minimal downtime.

Differentiator

Problem solved

Functional benefit

Brands

• ThermiRF+: Temperature-controlled radio frequency platform with 20W and 50W functionalities, the flagship multi-modality system.
• ThermiVa
• ThermiSmooth
• ThermiTight
• ThermiEye
• ThermiFit Mini

Products and services

• ThermiRF+ Multi-modality temperature-controlled radio frequency platform that serves as the foundational hardware for Thermi's aesthetic treatment hand-pieces. Uses 460 kHz RF energy with proprietary temperature-controlled algorithms and offers 20W and 50W functionalities for dermatological and general surgical procedures including electrocoagulation and hemostasis.
• ThermiVa Radio frequency treatment for vaginal rejuvenation using temperature-controlled RF technology to treat vulvovaginal laxity. Indicated in Europe for electrocoagulation of soft tissues.
• ThermiSmooth Radio frequency skin smoothing treatment that uses controlled heating to stimulate collagen production and improve skin appearance on face and body.
• ThermiTight Minimally-invasive tissue tightening treatment using injectable radio frequency to target deeper tissues and stimulate collagen remodeling.
• ThermiEye Radio frequency treatment specifically designed for the delicate eye area to reduce signs of aging and improve skin appearance around the eyes.
• ThermiFit Mini Non-invasive body sculpting device using controlled radio frequency heating with a silver-tipped 30mm reusable hand piece. Designed for larger body areas with no downtime and no surgery required.

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Celling BiosciencescoreStrategic or Co-development Partner · 1 January 2019Celling Biosciences acquired Thermi in 2019 and relocated the company to Austin, TX to leverage Celling's multi-million dollar laboratory and headquarters facilities. The partnership combines Celling's expertise in autologous cell therapy and regenerative biologics with Thermi's RF technology to create integrated restorative wellness solutions across medical specialties.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Venus Concept: Venus Concept develops minimally invasive and non-invasive aesthetic and dermatology devices including RF platforms (Venus Versa, Venus Viva). It competes directly with Thermi in the dermatology and aesthetic medical device market with a similar subscription-leaning model.
• InMode: InMode develops minimally invasive and non-invasive aesthetic medical devices including RF-based platforms (BodyTite, FaceTite, Morpheus8). It competes directly with Thermi in the RF aesthetic/dermatology space with a broader portfolio and stronger commercial scale.
• Cutera: Cutera manufactures laser and energy-based aesthetic devices including RF platforms for dermatology and plastic surgery. It competes with Thermi for the same provider customer base across skin rejuvenation and body contouring use cases.
• Cynosure (Hologic): Cynosure, part of Hologic, manufactures energy-based aesthetic and dermatology devices including RF platforms. It directly competes with Thermi across dermatology and plastic surgery practices in North America and globally.
• Solta Medical: Solta Medical (Bausch Health subsidiary) manufactures Thermage, a direct temperature-controlled RF skin tightening platform. Solta is Thermi's most direct competitor in RF-based aesthetic dermatology with overlapping provider customers and similar clinical positioning.

Emerging players

• Sciton: Sciton manufactures laser and light-based aesthetic and medical devices with some RF-adjacent offerings. It is an adjacent competitor targeting the same dermatology and plastic surgery provider base as Thermi, with comparable company size.

Broad incumbents

• AbbVie (Allergan Aesthetics): AbbVie's Allergan Aesthetics division is a major aesthetics incumbent that, while primarily a pharmaceutical (Botox, fillers) player, increasingly moves into device-adjacent categories and competes with Thermi for the same provider customer base and patient demand for non-invasive aesthetics.
• Alma Lasers: Alma Lasers manufactures a broad portfolio of aesthetic devices including RF, laser, and ultrasound systems. It competes with Thermi in dermatology/aesthetics with significantly broader global distribution and a more diversified modality portfolio.
• BTL Industries: BTL Industries is a large aesthetic device manufacturer with energy-based platforms including RF and HIFEM technologies (EMSCULPT, Exilis). It competes with Thermi in body contouring and skin tightening segments and operates at significantly larger scale.
• Lumenis: Lumenis is a global energy-based medical device company with laser, RF, and IPL platforms serving aesthetic, dermatology, and surgical markets. It competes with Thermi as a broader incumbent with deeper clinical evidence and global reach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/ThermiTight
• YouTubeyoutube.com/user/ThermiGen
• Facebookfacebook.com/1482033895349931
• LinkedInlinkedin.com/company/thermiaesthetics
• Instagraminstagram.com/thermi

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Thermi